2020
DOI: 10.21203/rs.3.rs-122534/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Obesity Is Associated with Severe Disease and Mortality in Patients with Coronavirus Disease 2019 (COVID-19)

Abstract: Background: The coronavirus disease 2019 (COVID-19) pandemic has led to global research with the aim of predicting which people are at greatest risk of developing severe disease and dying. The aim of this meta-analysis was to determine the associations between obesity and the severity of and mortality due to COVID-19. Methods: We searched the PubMed, EMBASE, Cochrane Library and Web of Science databases for studies evaluating the associations of obesity with COVID-19 . Odd risks (ORs) and 95% confidence interv… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 13 publications
1
3
0
Order By: Relevance
“…Similar to our finding, other studies have highlighted that obesity is associated with increased risk of COVID-19 [59,60]. Along the same lines, for COVID-19 patients, even if different across countries, obesity was one of the main risk factors associated with hospitalization and the critical evolution of the disease [11,[61][62][63][64][65]. Compared with nonobese patients, obese patients had a significantly increased risk of infection.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Similar to our finding, other studies have highlighted that obesity is associated with increased risk of COVID-19 [59,60]. Along the same lines, for COVID-19 patients, even if different across countries, obesity was one of the main risk factors associated with hospitalization and the critical evolution of the disease [11,[61][62][63][64][65]. Compared with nonobese patients, obese patients had a significantly increased risk of infection.…”
Section: Discussionsupporting
confidence: 90%
“…Compared with nonobese patients, obese patients had a significantly increased risk of infection. Clinically severe disease and mortality [11,62,[64][65][66] and obesity may be clinical predictors for adverse outcomes [14,63]. The explanation for this is the disproportionate impact of COVID-19 on pulmonary function in patients with obesity and severe obesity, in which obesity is associated with decreased expiratory reserve volume, functional capacity and respiratory system compliance.…”
Section: Discussionmentioning
confidence: 99%
“…Chronic inflammation in obesity initially occurs in adipose tissue, but later this process progresses to systemic inflammation. 18 There was a difference in the median values of inflammatory markers procalcitonin, IL-6 and D-dimer, which were higher in the obese group than non-obese, while the median value of ferritin was lower in the obese group than in the non-obese group, but the difference was not statistically significant. 24 The underlying mechanisms involve abnormalities in the balance of leptin and adiponectin, increased ACE-2 expression, altered pulmonary physiology and impaired lung function that may promote the development of respiratory viral infections in obese patients.…”
Section: Resultsmentioning
confidence: 76%
“…In the logistic regression, gender (male) was associated with HFNO success, and Table 2 indicates that the rate of obesity was 2.6 time smaller in males compared to females. The negative impact of obesity on the outcome of COVID-19 has been largely described, and this comorbid condition is associated with many technical difficulties in front of a respiratory failure [9,10].…”
Section: Dear Editormentioning
confidence: 99%